ace
convert
angiotensin
angiotensin
ii
carboxypeptidas
neg
regul
angiotensin
ii
product
cleav
singl
residu
angiotensin
ii
thu
interf
reninangiotensin
cascad
cascad
recent
demonstr
play
role
diffus
pulmonari
alveolar
injuri
mediat
interact
angiotensin
ii
angiotensin
ii
receptor
type
demonstr
vitro
cellsurfac
receptor
surfac
spike
protein
sar
coronaviru
suggest
possibl
sever
diffus
alveolar
damag
commonli
seen
patient
sar
may
least
part
consequ
effect
angiotensin
ii
downregulatori
effect
could
play
protect
role
experiment
pulmonari
infect
sar
coronaviru
infect
mice
reduc
express
lung
also
occur
human
caus
diffus
lung
injuri
find
reproduc
exposur
sar
coronaviru
spike
protein
absenc
replic
viru
murin
model
acut
lung
injuri
due
acid
aspir
sar
coronaviru
spike
protein
exacerb
lung
failur
downregul
reninangiotensin
system
sar
coronaviru
spike
proteininduc
lung
failur
could
mitig
inhibit
angiotensin
ii
receptor
type
receptor
mediat
angiotensin
iiinduc
vascular
permeabl
lung
injuri
separ
public
investig
demonstr
recombin
protect
mice
acid
aspirationinduc
lung
injuri
investig
also
note
polymorph
associ
progress
sar
basi
find
investig
propos
sever
pulmonari
alveolar
injuri
seen
patient
sar
consequ
sar
coronaviru
spike
surfac
proteinassoci
downregul
decreas
avail
impair
abil
downregul
reninangiotensin
system
exacerb
lung
injuri
author
suggest
recombin
protein
could
potenti
therapeut
agent
relat
pulmonari
infect
diffus
alveolar
injuri
intracellular
retrovir
restrict
factor
effect
bind
incom
retrovir
capsid
inhibit
replic
stage
prior
concurr
revers
transcript
appear
account
resist
old
world
monkey
infect
human
contrast
unabl
abort
intracellular
infect
despit
homolog
amino
acid
level
rhesu
monkey
counterpart
stoy
colleagu
explor
differ
simian
human
construct
chimera
human
rhesu
monkey
gene
sequenc
map
region
requir
restrict
approach
reveal
region
involv
restrict
spri
domain
singl
amino
acid
substitut
human
gene
product
arginin
prolin
amino
acid
posit
enabl
human
cell
block
replic
find
suggest
vulner
human
popul
consequ
mutat
remot
evolutionari
histori
investig
provid
evid
posit
select
within
relev
spri
domain
presum
consequ
ancient
exposur
retroviru
final
result
point
potenti
therapeut
valu
molecul
mimic
well
possibl
futur
target
gene
therapi
golden
pigment
produc
aureu
compromis
group
carotenoid
carotenoid
produc
fruit
veget
capabl
scaveng
free
radic
quench
singlet
oxygen
liu
colleagu
devis
set
experi
design
examin
hypothesi
carotenoid
produc
aureu
provid
surviv
advantag
organ
allow
resist
oxygendepend
bactericid
activ
phagocyt
cell
use
target
mutagenesi
heterolog
express
demonstr
mutant
knockout
aureu
impair
synthesi
carotenoid
suscept
kill
oxid
wildtyp
strain
inhibit
neutrophil
oxid
burst
elimin
rel
surviv
advantag
wildtyp
aureu
strain
capabl
normal
carotenoid
biosynthesi
mutant
aureu
strain
incap
abscess
format
subcutan
inject
mice
heterolog
express
aureu
carotenoid
streptococcu
pyogen
confer
rel
resist
oxid
kill
neutrophil
well
increas
virul
anim
model
infect
mixedfunct
oxidas
inhibitor
known
inhibit
pigment
format
aureu
dosedepend
fashion
parallel
increas
suscept
organ
kill
singlet
oxygen
well
decreas
surviv
rate
murin
whole
blood
observ
indic
target
carotenoid
aureu
may
provid
fruit
approach
develop
novel
therapeut
agent
direct
organ
schwartz
colleagu
identifi
patient
definit
probn
p
abl
cn
aspergillosi
n
p
receiv
treatment
voriconazol
either
clinic
trial
compassionateus
program
patient
receiv
system
antifung
agent
receiv
voriconazol
thirtyon
patient
also
underw
neurosurg
procedur
underw
craniotomi
abscess
resect
underw
abscess
drainag
patient
underw
shunt
patient
ommaya
reservoir
place
thirtytwo
patient
recipi
hematopoiet
stem
cell
transplant
hsct
allogen
wherea
receiv
solid
organ
transplant
isol
speciat
found
aspergillu
fumigatu
complet
partial
respons
voriconazol
achiev
patient
overal
hsct
recipi
thirtyon
percent
patient
aliv
last
followup
visit
hsct
recipi
solid
organ
transplant
recipi
surviv
multivari
analysi
found
hsct
signific
predictor
reduc
surviv
rate
wherea
neurosurg
procedur
associ
improv
surviv
rate
howev
patient
underw
procedur
less
like
multipl
brain
lesion
potenti
role
surgic
intervent
previous
suggest
review
survivor
cerebr
aspergillosi
undergon
neurosurg
procedur
miser
result
seem
first
glanc
quit
superior
previous
publish
data
indic
respons
therapi
occur
patient
fatal
rate
cn
aspergillosi
solid
organ
transplant
recipi
approach
although
affect
studi
observ
natur
like
select
bia
data
strongli
suggest
voriconazol
therapi
effect
patient
cn
aspergillosi
furthermor
although
object
made
regard
find
neurosurg
intervent
ie
patient
like
singl
lesion
consid
capabl
surviv
procedur
avail
aggress
neurosurg
colleagu
may
also
invalu
improv
surviv
rate
devast
infect
crabtre
jh
burchett
rj
surgic
salvag
periton
dialysi
cathet
chronic
exitsit
tunnel
infect
j
surg
patient
chronic
infect
involv
exit
site
tunnel
portion
periton
dialysi
cathet
treatment
antibiot
local
care
often
unsuccess
case
remov
cathet
usual
recommend
one
less
drastic
method
allow
salvag
infect
catheterunroof
tunnel
tract
remov
superfici
cathet
cuffha
use
publish
evid
benefit
scanti
procedur
use
crabtre
burchett
consecut
patient
chronic
periton
dialysi
cathet
infect
present
mean
durat
month
success
result
procedur
consist
excis
shave
superfici
cuff
identif
mobil
incis
along
cours
cathet
exitsit
skin
inflammatori
tissu
excis
cathet
shave
tube
segment
move
wound
secur
adjac
skin
surfac
tinctur
benzoin
steril
adhes
strip
wound
pack
open
allow
heal
periton
dialysi
allow
immedi
antibiot
administ
oral
week
wound
heal
complet
mean
period
month
rang
month
mean
followup
period
month
person
nasal
carriag
aureu
develop
infect
involv
deep
cuff
month
three
patient
subsequ
cathet
remov
periton
without
exitsit
tunnel
infect
month
procedureat
least
perform
teamappear
highli
effect
mean
cathet
preserv
allow
continu
periton
dialysi
without
interrupt
